194 related articles for article (PubMed ID: 29463369)
81. Glycyrrhizin Acid and Glycyrrhetinic Acid Modified Polyethyleneimine for Targeted DNA Delivery to Hepatocellular Carcinoma.
Cao M; Gao Y; Zhan M; Qiu N; Piao Y; Zhou Z; Shen Y
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614879
[TBL] [Abstract][Full Text] [Related]
82. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Zhao R; Li T; Zheng G; Jiang K; Fan L; Shao J
Biomaterials; 2017 Oct; 143():1-16. PubMed ID: 28755539
[TBL] [Abstract][Full Text] [Related]
83. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells.
Chen YN; Cheng CC; Chen JC; Tsauer W; Hsu SL
Br J Pharmacol; 2003 Oct; 140(3):461-70. PubMed ID: 12970086
[TBL] [Abstract][Full Text] [Related]
84. Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer.
Chang JE; Yoon IS; Sun PL; Yi E; Jheon S; Shim CK
J Photochem Photobiol B; 2014 Nov; 140():49-56. PubMed ID: 25090224
[TBL] [Abstract][Full Text] [Related]
85. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF
Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130
[TBL] [Abstract][Full Text] [Related]
86. iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy.
Zhang J; Hu J; Chan HF; Skibba M; Liang G; Chen M
Nanomedicine; 2016 Jul; 12(5):1303-11. PubMed ID: 26964482
[TBL] [Abstract][Full Text] [Related]
87. [Studies on the liver targeting of norcantharindin microemulsion].
Zhang L; Xiang D; Hong Z; Zhang ZR
Yao Xue Xue Bao; 2004 Aug; 39(8):650-5. PubMed ID: 15563071
[TBL] [Abstract][Full Text] [Related]
88. Effect of norcantharidin on the proliferation, apoptosis, and cell cycle of human mesangial cells.
Ye K; Wei Q; Gong Z; Huang Y; Liu H; Li Y; Peng X
Ren Fail; 2017 Nov; 39(1):458-464. PubMed ID: 28393592
[TBL] [Abstract][Full Text] [Related]
89. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
90. Glycyrrhetinic acid as a hepatocyte targeting unit for an anticancer drug delivery system with enhanced cell type selectivity.
Singh H; Kim SJ; Kang DH; Kim HR; Sharma A; Kim WY; Kang C; Kim JS
Chem Commun (Camb); 2018 Oct; 54(87):12353-12356. PubMed ID: 30324188
[TBL] [Abstract][Full Text] [Related]
91. Synthesis, in vitro and in vivo evaluation of new norcantharidin-conjugated hydroxypropyltrimethyl ammonium chloride chitosan derivatives as polymer therapeutics.
Xu X; Li Y; Wang F; Lv L; Liu J; Li M; Guo A; Jiang J; Shen Y; Guo S
Int J Pharm; 2013 Sep; 453(2):610-9. PubMed ID: 23742972
[TBL] [Abstract][Full Text] [Related]
92. Tumor Microenvironment ROS/pH Cascade-Responsive Supramolecular Nanoplatform with ROS Regeneration Property for Enhanced Hepatocellular Carcinoma Therapy.
Shi J; Wang Y; Wu Y; Li J; Fu C; Li Y; Xie X; Fan X; Hu Y; Hu C; Zhang J
ACS Appl Mater Interfaces; 2024 Feb; 16(6):7576-7592. PubMed ID: 38316581
[TBL] [Abstract][Full Text] [Related]
93. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
[TBL] [Abstract][Full Text] [Related]
94. SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy.
Ma X; Cheng Z; Jin Y; Liang X; Yang X; Dai Z; Tian J
Biomaterials; 2014 Mar; 35(9):2878-89. PubMed ID: 24411331
[TBL] [Abstract][Full Text] [Related]
95. Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells.
Tang ZH; Li T; Chang LL; Zhu H; Tong YG; Chen XP; Wang YT; Lu JJ
J Agric Food Chem; 2014 Dec; 62(49):11910-6. PubMed ID: 25403108
[TBL] [Abstract][Full Text] [Related]
96. [18β-glycyrrhetinic acid piperazine derivative A30 inhibits the proliferation of SMMC-7721 hepatoma cells].
Zhong L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Sep; 33(9):1212-1216. PubMed ID: 29089079
[TBL] [Abstract][Full Text] [Related]
97. Liposomal Nanodrug Based on Norcantharidin Derivative for Increased in Vivo Activity.
Kuang H; Wang P; Wang Y; Li J; Yu J; Jia L; Li S; Ma Y; Liu H; He Z; Wang Y
AAPS PharmSciTech; 2023 May; 24(5):118. PubMed ID: 37165275
[TBL] [Abstract][Full Text] [Related]
98. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer.
Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q
Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711
[TBL] [Abstract][Full Text] [Related]
99. Decorating protein nanospheres with lactoferrin enhances oral COX-2 inhibitor/herbal therapy of hepatocellular carcinoma.
Abdelmoneem MA; Mahmoud M; Zaky A; Helmy MW; Sallam M; Fang JY; Elkhodairy KA; Elzoghby AO
Nanomedicine (Lond); 2018 Oct; 13(19):2377-2395. PubMed ID: 30346255
[TBL] [Abstract][Full Text] [Related]
100. [Preparation of the immunotoxin 2E8-norcantharidin and its targeting killing effect in vitro].
Li LX; Tang YM; Zhang HZ; Shen HQ; Qian BQ; Luo CF
Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):493-7. PubMed ID: 19099803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
